Cephalon Reports Strong First Quarter Earnings
... Generic OTFC 27,318 - 27,318 34,020 - 34,020 fentora 38,933 - 38,933 31,690 - 31,690 AMRIX ...24%) Generic OTFC (20%) 0% (20%) fentora 23% 0% 23% AMRIX ...Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
FRAZER, Pa., Jan. 25 /PRNewswire-FirstCall/ -- Cephalon, Inc., (Nasdaq: CEPH) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company's supplemental New Drug Application (sNDA) for FENTORA(R) (fentanyl buccal tablet) [C-II] for the management of breakthrough p...Cephalon Submits Supplemental New Drug Application for FENTORA
Indication Sought for Breakthrough Pain Associated with Chronic Pain Conditions in Patients Who are Already Taking Opioid Medications Around-the-Clock FRAZER, Pa., Nov. 12 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today announced it has submitted a...Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
FRAZER, Pa., Sept. 13 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH) today communicated with healthcare professionals to clarify the appropriate patient selection, dosing and administration for FENTORA(R) (fentanyl buccal tablet) [C-II]. The company is sharing this information with th...Cephalon's New Product Launches Pace Record 2008 Sales
... - 19,915 31,471 - 31,471 fentora 38,609 - 38,609 33,912 ... Generic OTFC (37) - (37) fentora 14 - 14 AMRIX ...- 95,760 129,033 - 129,033 fentora 155,246 - 155,246 135,136 ...Cephalon Reports Another Strong Quarter
... 19,569 - 19,569 fentora 41,330 - ... 32,689 - 32,689 fentora 33,193 - ... (40) - (40) fentora 25 - ...Cephalon Exceeds Both Sales and Earnings Guidance for Second Quarter of 2008
... - 28,958 30,853 - 30,853 fentora 36,374 - 36,374 36,341 ... (6%) - (6%) fentora 0% - ... - 56,276 64,873 - 64,873 fentora 75,307 - 75,307 68,031 ...Cephalon Files Patent Infringement Lawsuit Against Watson Pharmaceuticals
...04 and 6,974,590 patents do not expire until 2019. fentora was approved by the U.S. Food and Drug Administrat...e United States. Watson alleges that the above two fentora patents are invalid, unenforceable and/or will not...Executive Vice President and General Counsel. "The fentora patents were approved by the United States Patent ...Cephalon Notified of Generic Fentanyl Buccal Tablet Filing
...sion of FENTORA(R) (fentanyl buccal tablet) [C-II]. In its Notice Letter, Watson alleges that the U.S. Patent Numbers 6,200,604 and 6,974,590 covering fentora are invalid, unenforceable and/or will not be infringed by Watson's manufacture, use or sale of the product described in its ANDA. Cephalon currentl...Cephalon's 2007 Results Exceed Full Year Sales and Earnings Guidance
... 31,471 - 31,471 fentora 33,912 - 33,91... 46,630 - 46,630 fentora 29,250 - 29,25... (33%) 0% (33%) fentora 16% 0% ...